| 3.3 |
9.9 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.9 |
8.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.6 |
7.8 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 2.1 |
6.4 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 2.1 |
8.5 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.9 |
1.9 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 1.8 |
5.4 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 1.7 |
5.1 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 1.7 |
1.7 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 1.6 |
4.8 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.6 |
6.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.6 |
1.6 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.6 |
6.3 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.5 |
4.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 1.5 |
7.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.4 |
2.9 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 1.4 |
4.3 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.4 |
4.2 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.4 |
5.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.4 |
5.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.3 |
4.0 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 1.3 |
9.1 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 1.3 |
5.2 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 1.3 |
12.8 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.3 |
5.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 1.3 |
6.4 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 1.2 |
8.7 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.2 |
3.6 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.2 |
4.8 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 1.2 |
5.9 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.2 |
1.2 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 1.1 |
4.6 |
GO:0060022 |
hard palate development(GO:0060022) |
| 1.1 |
3.4 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 1.1 |
1.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.1 |
7.6 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.1 |
9.6 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.1 |
3.2 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.0 |
8.3 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 1.0 |
2.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.0 |
1.0 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 1.0 |
3.0 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 1.0 |
5.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.0 |
6.0 |
GO:0060486 |
Clara cell differentiation(GO:0060486) |
| 1.0 |
2.9 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.0 |
5.7 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.9 |
1.9 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.9 |
4.7 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.9 |
2.8 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.9 |
2.8 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.9 |
3.7 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.9 |
2.8 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.9 |
5.5 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.9 |
2.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.9 |
2.7 |
GO:0030421 |
defecation(GO:0030421) |
| 0.9 |
4.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.9 |
8.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.9 |
2.7 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.9 |
3.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.9 |
14.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.9 |
3.5 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.9 |
5.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.9 |
5.2 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.9 |
2.6 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.9 |
4.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.9 |
0.9 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.8 |
2.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.8 |
0.8 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.8 |
0.8 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.8 |
3.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 |
3.3 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.8 |
5.7 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.8 |
7.3 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.8 |
1.6 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.8 |
0.8 |
GO:2000136 |
regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
| 0.8 |
2.4 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.8 |
8.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.8 |
7.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.8 |
2.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.8 |
8.6 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.8 |
2.3 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.8 |
0.8 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.8 |
0.8 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.8 |
2.3 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.8 |
0.8 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.8 |
3.0 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.8 |
3.8 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.8 |
3.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.7 |
0.7 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.7 |
1.5 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 |
3.7 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.7 |
3.7 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.7 |
6.6 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.7 |
2.9 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.7 |
2.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.7 |
1.4 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.7 |
6.4 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.7 |
2.1 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.7 |
7.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.7 |
0.7 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.7 |
2.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.7 |
1.4 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.7 |
5.5 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.7 |
4.1 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.7 |
3.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 |
4.7 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.7 |
4.7 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.7 |
2.0 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.7 |
2.0 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.7 |
7.2 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.6 |
2.6 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.6 |
1.9 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.6 |
1.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.6 |
5.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.6 |
0.6 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.6 |
1.9 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.6 |
0.6 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.6 |
0.6 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.6 |
3.1 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.6 |
3.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.6 |
5.5 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.6 |
3.0 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.6 |
1.8 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.6 |
19.9 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.6 |
1.2 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.6 |
0.6 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.6 |
1.8 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.6 |
2.4 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.6 |
5.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.6 |
2.9 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.6 |
2.9 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.6 |
0.6 |
GO:0072191 |
ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
| 0.6 |
2.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
0.6 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.6 |
2.3 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.6 |
2.3 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.6 |
1.1 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.6 |
2.8 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.6 |
1.7 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.6 |
2.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.6 |
5.7 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.6 |
1.7 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.6 |
1.7 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 |
3.9 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.6 |
1.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.6 |
0.6 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.6 |
1.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.6 |
2.8 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.6 |
2.8 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.5 |
2.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.5 |
3.3 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.5 |
3.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.5 |
2.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.5 |
1.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.5 |
2.7 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.5 |
2.7 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.5 |
3.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.5 |
1.6 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.5 |
1.6 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.5 |
0.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.5 |
1.6 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.5 |
2.6 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.5 |
1.6 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.5 |
2.6 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 |
8.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 |
2.1 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.5 |
1.6 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
5.7 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.5 |
1.5 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.5 |
1.5 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.5 |
2.0 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 |
4.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.5 |
2.0 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 0.5 |
1.5 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 |
1.5 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.5 |
3.0 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.5 |
2.0 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 |
4.5 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.5 |
2.5 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.5 |
1.0 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.5 |
2.5 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.5 |
4.0 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.5 |
0.5 |
GO:0021861 |
forebrain radial glial cell differentiation(GO:0021861) |
| 0.5 |
0.5 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.5 |
1.5 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.5 |
1.0 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.5 |
2.9 |
GO:0021871 |
forebrain regionalization(GO:0021871) |
| 0.5 |
1.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.5 |
0.5 |
GO:0071772 |
response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.5 |
0.5 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.5 |
2.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.5 |
1.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
1.9 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.5 |
3.3 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.5 |
2.8 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.5 |
1.9 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.5 |
5.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
3.3 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.5 |
0.5 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 |
0.9 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
1.9 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.5 |
2.8 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.5 |
0.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.5 |
3.2 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.5 |
3.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.5 |
3.2 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.5 |
1.4 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.5 |
1.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.5 |
0.9 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.5 |
3.6 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.4 |
1.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.4 |
1.8 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.4 |
1.3 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.4 |
1.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 |
3.1 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.4 |
0.9 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.4 |
1.7 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.4 |
1.3 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.4 |
0.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
1.7 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 |
2.2 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.4 |
3.0 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.4 |
2.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.4 |
1.3 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.4 |
2.6 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.4 |
1.7 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.4 |
1.7 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.4 |
0.4 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.4 |
1.7 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.4 |
0.8 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.4 |
1.2 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.4 |
9.9 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.4 |
2.9 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.4 |
1.2 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.4 |
1.2 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.4 |
0.4 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.4 |
1.2 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.4 |
1.6 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.4 |
0.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
1.2 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.4 |
0.4 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.4 |
0.8 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 |
4.8 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.4 |
2.0 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 |
0.4 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.4 |
0.8 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.4 |
1.2 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.4 |
1.2 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.4 |
0.8 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 |
5.8 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.4 |
2.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.4 |
1.1 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.4 |
0.4 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.4 |
1.1 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.4 |
1.5 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.4 |
1.9 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
0.8 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.4 |
4.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 |
2.2 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.4 |
0.4 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.4 |
1.1 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.4 |
0.7 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.4 |
2.6 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 |
2.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 |
6.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.4 |
1.5 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.4 |
1.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 |
1.5 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.4 |
2.9 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 |
6.9 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.4 |
0.4 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.4 |
2.2 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.4 |
1.8 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.4 |
1.1 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.4 |
0.4 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.4 |
1.1 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.4 |
1.4 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 |
1.8 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.4 |
1.8 |
GO:0060026 |
convergent extension(GO:0060026) |
| 0.4 |
1.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.3 |
1.0 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
2.4 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.3 |
1.7 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.3 |
1.4 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 |
0.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.3 |
2.1 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.3 |
0.3 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.3 |
0.7 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.3 |
1.0 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 |
7.2 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.3 |
1.7 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.3 |
1.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
1.0 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.3 |
1.7 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.3 |
3.7 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.3 |
1.4 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.3 |
2.0 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.3 |
1.3 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 |
0.7 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) protein localization to axon(GO:0099612) |
| 0.3 |
1.3 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.3 |
1.7 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 |
4.0 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
0.7 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.3 |
1.0 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.3 |
0.3 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.3 |
9.9 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.3 |
1.3 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.3 |
1.0 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.3 |
1.3 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
2.3 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
0.3 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.3 |
0.3 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.3 |
1.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.3 |
2.0 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 |
7.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
1.0 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 |
1.3 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.3 |
1.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 |
2.6 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.3 |
1.0 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.3 |
10.7 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.3 |
1.6 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
1.0 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.3 |
1.0 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.3 |
1.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.3 |
2.2 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 |
14.1 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.3 |
1.0 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 |
0.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.3 |
0.6 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.3 |
1.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.3 |
0.3 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.3 |
1.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
1.3 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.3 |
0.3 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.3 |
2.8 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.3 |
0.9 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.3 |
2.5 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.3 |
1.9 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.3 |
0.9 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.3 |
4.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
2.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 |
1.2 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.3 |
0.9 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.3 |
0.6 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 |
0.6 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.3 |
1.5 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.3 |
1.8 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 |
1.5 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 |
0.9 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.3 |
0.9 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.3 |
0.9 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.3 |
0.3 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.3 |
1.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.3 |
0.9 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 |
0.6 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 |
0.9 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 |
2.0 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.3 |
0.6 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.3 |
1.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.3 |
0.6 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.3 |
0.3 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.3 |
1.4 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.3 |
0.9 |
GO:0034476 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.3 |
1.1 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) specification of axis polarity(GO:0065001) |
| 0.3 |
0.3 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
1.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.3 |
0.8 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.3 |
0.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 |
0.6 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.3 |
0.8 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.3 |
1.7 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.3 |
1.4 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 |
0.8 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.3 |
1.4 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.3 |
1.4 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.3 |
0.8 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 |
9.7 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.3 |
0.8 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 |
3.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.3 |
2.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.3 |
1.9 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.3 |
0.8 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.3 |
2.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
3.5 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 |
0.5 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.3 |
3.2 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.3 |
1.6 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.3 |
0.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
0.8 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.3 |
0.3 |
GO:0071305 |
cellular response to vitamin D(GO:0071305) |
| 0.3 |
0.3 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.3 |
1.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 |
0.8 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.3 |
0.8 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 |
0.3 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.3 |
1.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
1.5 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.3 |
0.5 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.3 |
0.5 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.3 |
0.8 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.3 |
0.8 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.2 |
1.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
1.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
2.0 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
1.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
1.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
0.2 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.5 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
2.9 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.2 |
0.7 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
0.2 |
GO:1990542 |
mitochondrial transmembrane transport(GO:1990542) |
| 0.2 |
0.2 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.2 |
2.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
1.7 |
GO:1902893 |
regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.2 |
0.2 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.2 |
0.7 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
1.4 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.2 |
0.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
1.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.2 |
0.9 |
GO:0003071 |
renal system process involved in regulation of blood volume(GO:0001977) renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
| 0.2 |
0.7 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
5.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
2.6 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.2 |
0.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
0.5 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.2 |
0.9 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.2 |
0.7 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.2 |
0.7 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
1.8 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.2 |
0.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.9 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.2 |
0.7 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
5.7 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.2 |
0.2 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.2 |
0.5 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.2 |
0.2 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 |
0.2 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.2 |
0.7 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.2 |
0.2 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
1.1 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
0.9 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
2.7 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.7 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.2 |
0.2 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.2 |
2.0 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.2 |
0.9 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.7 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
1.3 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 |
5.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
0.2 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 |
0.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
0.7 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
3.5 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.2 |
0.7 |
GO:0046548 |
amacrine cell differentiation(GO:0035881) retinal rod cell development(GO:0046548) |
| 0.2 |
2.0 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 |
0.7 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
1.9 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.2 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.2 |
0.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.2 |
1.3 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
0.2 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.2 |
0.6 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
3.4 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.6 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.2 |
0.2 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
0.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.2 |
0.8 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 |
0.4 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
0.4 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.2 |
1.1 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.2 |
1.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 |
0.4 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.2 |
0.2 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.2 |
0.4 |
GO:0009913 |
epidermal cell differentiation(GO:0009913) |
| 0.2 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
2.9 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.2 |
0.6 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.2 |
0.6 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 |
1.8 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.2 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.2 |
0.4 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
0.6 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
1.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
0.8 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
0.8 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 |
0.6 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 |
0.6 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.2 |
0.4 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.2 |
2.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
2.4 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.6 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.2 |
1.4 |
GO:0048679 |
regulation of axon regeneration(GO:0048679) |
| 0.2 |
1.4 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 |
0.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
1.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.2 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
2.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.8 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
2.7 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.2 |
1.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
0.6 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
0.6 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
1.0 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 |
1.0 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.2 |
0.8 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
1.0 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
1.0 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.2 |
0.8 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 |
0.6 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.2 |
0.4 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 |
0.6 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.2 |
1.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
0.6 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
0.2 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
0.6 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.2 |
0.4 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
2.0 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 |
1.8 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.2 |
0.4 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 |
0.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
0.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.4 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 |
1.4 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
0.7 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.5 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.2 |
0.5 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.2 |
0.5 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 |
3.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
0.2 |
GO:1905048 |
regulation of metallopeptidase activity(GO:1905048) |
| 0.2 |
0.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.2 |
0.9 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.2 |
2.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
1.9 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.2 |
0.9 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.2 |
1.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
0.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.2 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
0.7 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
0.7 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 |
1.6 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 |
0.7 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 |
0.3 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 |
1.7 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 |
0.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
0.5 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
0.3 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 |
1.4 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.2 |
1.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.2 |
0.3 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
1.0 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 |
0.3 |
GO:0097502 |
protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
| 0.2 |
0.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
1.3 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.2 |
0.5 |
GO:0071105 |
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-11(GO:0071105) negative regulation of metanephros development(GO:0072217) |
| 0.2 |
0.5 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.2 |
0.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
2.0 |
GO:0036093 |
germ cell proliferation(GO:0036093) |
| 0.2 |
0.5 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
0.8 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.2 |
1.1 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.2 |
0.2 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.2 |
3.4 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.2 |
1.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
2.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 |
0.8 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
2.1 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.2 |
0.5 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.2 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.2 |
0.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 |
0.5 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 |
0.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.2 |
0.2 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.2 |
0.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
0.3 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 0.2 |
0.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
1.3 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
0.5 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.2 |
0.6 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
2.0 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
0.9 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
0.5 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
0.6 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 |
0.9 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 |
3.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
0.3 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.2 |
7.2 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.2 |
0.2 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
0.6 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
6.7 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.2 |
0.3 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.2 |
0.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 |
1.1 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
0.2 |
GO:0060231 |
mesenchymal to epithelial transition(GO:0060231) |
| 0.2 |
0.5 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
10.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.4 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
1.8 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.1 |
0.4 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
1.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.6 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.9 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.4 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
1.6 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
1.9 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.6 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.1 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.4 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
1.7 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.3 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.3 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.4 |
GO:0002329 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.7 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.3 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
1.7 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
2.7 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.1 |
1.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.6 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.3 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.1 |
0.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
1.5 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
2.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.8 |
GO:0030540 |
female genitalia development(GO:0030540) |
| 0.1 |
0.4 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
1.4 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.7 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
0.1 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.1 |
0.1 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.1 |
1.0 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
1.4 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.7 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
1.5 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.1 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.1 |
0.9 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.4 |
GO:0090178 |
regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
| 0.1 |
0.4 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
3.6 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.1 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
0.4 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.5 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
1.2 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
2.5 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.5 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.5 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.8 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.1 |
GO:0042640 |
anagen(GO:0042640) |
| 0.1 |
1.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.3 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.1 |
0.9 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.1 |
0.1 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 |
2.5 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.1 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
3.1 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
1.3 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.8 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
0.8 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
2.3 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.6 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
0.7 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
0.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.9 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.5 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.2 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
0.2 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.1 |
1.8 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.9 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.4 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
1.0 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
1.5 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
1.2 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
1.7 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.8 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 |
0.4 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
9.7 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.2 |
GO:0050000 |
chromosome localization(GO:0050000) establishment of chromosome localization(GO:0051303) |
| 0.1 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.4 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.1 |
0.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.9 |
GO:0019359 |
nicotinamide nucleotide biosynthetic process(GO:0019359) |
| 0.1 |
1.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.8 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.1 |
0.4 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.1 |
1.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.6 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.1 |
0.8 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
1.0 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.1 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.1 |
0.6 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.3 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.2 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.7 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.1 |
0.3 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.3 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.1 |
0.6 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
0.3 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.1 |
0.5 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.1 |
0.6 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.1 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.9 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
1.7 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.3 |
GO:0097012 |
response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.7 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.5 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
1.7 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.3 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.8 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
2.9 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
0.1 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.7 |
GO:0098534 |
centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.1 |
1.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
0.4 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
0.3 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.1 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.1 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.1 |
1.3 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
1.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.3 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.3 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.5 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.1 |
0.9 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.3 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
1.0 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
1.7 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.1 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
0.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.4 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 |
1.0 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.2 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.1 |
0.3 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 |
0.9 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
2.7 |
GO:0006073 |
glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.1 |
0.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.9 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
0.2 |
GO:0035136 |
embryonic forelimb morphogenesis(GO:0035115) forelimb morphogenesis(GO:0035136) |
| 0.1 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.3 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 |
0.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.3 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.2 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
3.5 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.1 |
0.3 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.9 |
GO:0009148 |
CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate metabolic process(GO:0009147) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.1 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.3 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 |
0.7 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 |
2.5 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.1 |
0.6 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.2 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.5 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.1 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.1 |
0.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.8 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
1.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.3 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
1.2 |
GO:0098868 |
endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.1 |
0.1 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 0.1 |
0.1 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.1 |
0.2 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
0.3 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.3 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.5 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.4 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.1 |
0.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.1 |
0.1 |
GO:0060688 |
regulation of morphogenesis of a branching structure(GO:0060688) |
| 0.1 |
0.7 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.6 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
1.0 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 |
0.2 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
1.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
1.2 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
0.1 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.6 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 |
1.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.7 |
GO:0051351 |
positive regulation of ligase activity(GO:0051351) |
| 0.1 |
0.2 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.1 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.7 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.3 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.1 |
1.2 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.1 |
0.3 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
0.2 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.1 |
0.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.2 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.1 |
0.2 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.1 |
0.4 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
0.2 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.3 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
1.9 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 |
0.8 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.1 |
1.1 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.2 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.7 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.7 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.6 |
GO:0015781 |
nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 |
1.3 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.1 |
0.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
10.2 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.1 |
0.1 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.1 |
0.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.1 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 |
0.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.4 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.1 |
0.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.5 |
GO:0000097 |
sulfur amino acid biosynthetic process(GO:0000097) |
| 0.1 |
0.2 |
GO:0046850 |
regulation of bone remodeling(GO:0046850) |
| 0.1 |
0.9 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.1 |
0.2 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.1 |
0.1 |
GO:1902956 |
regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
| 0.1 |
0.6 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
2.1 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.1 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.4 |
GO:0007249 |
I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.1 |
0.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
2.3 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.1 |
1.1 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.8 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 |
0.1 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.1 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.4 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.9 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.3 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.1 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
0.1 |
GO:0071472 |
cellular response to salt stress(GO:0071472) |
| 0.1 |
0.1 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.1 |
1.3 |
GO:0001942 |
hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
| 0.1 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.4 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 |
0.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.5 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
1.2 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.1 |
0.2 |
GO:0051896 |
regulation of protein kinase B signaling(GO:0051896) |
| 0.1 |
0.1 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.1 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
0.7 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.1 |
0.3 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.4 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.1 |
GO:0044773 |
mitotic DNA damage checkpoint(GO:0044773) mitotic DNA integrity checkpoint(GO:0044774) |
| 0.1 |
0.4 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.1 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
0.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 |
0.1 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
0.2 |
GO:0046398 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.1 |
0.6 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.8 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.1 |
0.3 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.1 |
GO:0090086 |
regulation of protein deubiquitination(GO:0090085) negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.6 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.1 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.1 |
0.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.1 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
0.4 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.7 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.7 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.2 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.4 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.3 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.7 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
1.3 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 |
1.3 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.8 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.3 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.1 |
0.2 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.2 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
12.3 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.1 |
0.4 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.2 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
1.2 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.1 |
GO:0043312 |
neutrophil activation involved in immune response(GO:0002283) neutrophil activation(GO:0042119) neutrophil degranulation(GO:0043312) regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.1 |
0.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.1 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.6 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.3 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.1 |
0.4 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.0 |
0.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.1 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.0 |
1.0 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.0 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.0 |
0.2 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.1 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.0 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.0 |
0.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
1.1 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.0 |
0.2 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
2.3 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.0 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.2 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.0 |
0.1 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.0 |
0.4 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
1.7 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.3 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
1.8 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.7 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.2 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.0 |
0.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.7 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.1 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.0 |
0.4 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.0 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.0 |
0.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
1.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.0 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.3 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.2 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.0 |
0.3 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.0 |
0.2 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.7 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 |
2.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
1.9 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.2 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.0 |
0.1 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.6 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.2 |
GO:0060767 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.0 |
0.8 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0032200 |
telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
| 0.0 |
0.1 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.0 |
0.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.3 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.3 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.0 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.0 |
0.2 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 |
0.3 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.1 |
GO:2000678 |
negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 |
0.0 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.0 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.0 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.0 |
0.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.1 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.2 |
GO:0031100 |
organ regeneration(GO:0031100) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.3 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.1 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.1 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.0 |
0.1 |
GO:0002534 |
cytokine production involved in inflammatory response(GO:0002534) |
| 0.0 |
0.1 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
0.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.0 |
0.2 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.0 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.0 |
0.2 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.0 |
0.0 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.1 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.3 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.7 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.2 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.2 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 |
0.1 |
GO:0031585 |
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.1 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.0 |
0.7 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.0 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.0 |
0.7 |
GO:0032835 |
glomerulus development(GO:0032835) |
| 0.0 |
0.1 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.0 |
0.0 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0042307 |
positive regulation of protein import into nucleus(GO:0042307) positive regulation of protein import(GO:1904591) |
| 0.0 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.2 |
GO:0043242 |
negative regulation of protein complex disassembly(GO:0043242) negative regulation of protein depolymerization(GO:1901880) |
| 0.0 |
1.8 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.0 |
GO:0002475 |
antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.0 |
0.2 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.0 |
0.6 |
GO:0045089 |
positive regulation of innate immune response(GO:0045089) |
| 0.0 |
0.7 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.2 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.5 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.3 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.0 |
0.0 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 |
0.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.1 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.0 |
GO:2001169 |
regulation of ATP biosynthetic process(GO:2001169) |
| 0.0 |
0.4 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.0 |
0.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.0 |
0.0 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.2 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.6 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.2 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
0.1 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.3 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
0.4 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.2 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0016073 |
snRNA metabolic process(GO:0016073) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.0 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.1 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.3 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.0 |
0.1 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.9 |
GO:0050953 |
sensory perception of light stimulus(GO:0050953) |
| 0.0 |
0.1 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.1 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.0 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.1 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.0 |
0.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.0 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.0 |
GO:0061620 |
glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.0 |
0.2 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.0 |
0.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.0 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.0 |
0.1 |
GO:0042345 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.0 |
0.0 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.0 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.0 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
